When did AngioDynamics report Q4 2025 earnings?

AngioDynamics (ANGO) reported Q4 2025 earnings on January 6, 2026 before market open.

What were AngioDynamics's Q4 2025 revenue and EPS?

AngioDynamics reported revenue of $79.4M and diluted EPS of $-0.15 for Q4 2025.

Did AngioDynamics beat estimates in Q4 2025?

Revenue beat the consensus estimate of $76.4M by $3.0M. EPS missed the consensus estimate of $-0.10 by $0.05.

How did AngioDynamics's Q4 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 9.0% from $72.8M a year earlier and diluted EPS declined 275.0% from $-0.04.

Where can I find AngioDynamics's Q4 2025 SEC filings?

You can read the 8-K earnings release (0001140361-26-000341) and the 10-Q periodic report (0001275187-26-000003) directly on SEC EDGAR. The filing index links above go to sec.gov.

AngioDynamics ANGO Q4 2025 earnings

Reported January 6, 2026 · Before market open

Revenue$79.4MBeat by $3.0M Diluted EPS-$0.15Miss by $0.05

Revenue estimate$76.4M

EPS estimate-$0.10

Next report

Jul 21, 2026 (In 4 weeks)

Revenue estimate$80.2M

EPS estimate-$0.11

Versus estimates

Revenue

Q1 2026$78.4MBeat by $1.7M

Q4 2025$79.4MBeat by $3.0M

Q3 2025$75.7MMiss by $601.0K Q2 2025$80.2MBeat by $5.9M Q1 2025$72.0MMiss by $2.3M Q4 2024$72.8MBeat by $2.3M

Diluted EPS

Q1 2026-$0.07Beat by $0.04

Q4 2025-$0.15Miss by $0.05

Q3 2025-$0.10Beat by $0.04 Q2 2025-$0.03Beat by $0.10 Q1 2025$0.03Beat by $0.16 Q4 2024-$0.04Beat by $0.07

Ask the moment AngioDynamics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did AngioDynamics report Q4 2025 earnings?: AngioDynamics (ANGO) reported Q4 2025 earnings on January 6, 2026 before market open.
What were AngioDynamics's Q4 2025 revenue and EPS?: AngioDynamics reported revenue of $79.4M and diluted EPS of $-0.15 for Q4 2025.
Did AngioDynamics beat estimates in Q4 2025?: Revenue beat the consensus estimate of $76.4M by $3.0M. EPS missed the consensus estimate of $-0.10 by $0.05.
How did AngioDynamics's Q4 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 9.0% from $72.8M a year earlier and diluted EPS declined 275.0% from $-0.04.
Where can I find AngioDynamics's Q4 2025 SEC filings?: You can read the 8-K earnings release (0001140361-26-000341) and the 10-Q periodic report (0001275187-26-000003) directly on SEC EDGAR. The filing index links above go to sec.gov.